The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state

Overview of attention for article published in Thrombosis Research, July 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 48,071 followers.

RT @jlsteeg: Los pacientes tratados con nilotinib exhiben parámetros protrombóticos, aunque reciban AAS. - PubMed - NCBI https://t.co/Dx7HD…

RT @jlsteeg: Los pacientes tratados con nilotinib exhiben parámetros protrombóticos, aunque reciban AAS. - PubMed - NCBI https://t.co/Dx7HD…

Los pacientes tratados con nilotinib exhiben parámetros protrombóticos, aunque reciban AAS. - PubMed - NCBI https://t.co/Dx7HDwScSD

The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state. https://t.co/f1KfCPfQ5U #leukemia https://t.co/LdXO0YYggt

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.